with low insulin sensitivity (SI) also have reduced whole body maximal oxygen uptake. The objectives of this study were to determine 1) whether muscle mitochondrial function was independently related to SI after being adjusted for known determinants of SI and 2) whether lower SI among African-American (AA) vs. Caucasian-American (CA) women was due to lower muscle mitochondrial function among AA women. Subjects were 37 CA and 22 AA premenopausal women (age: 33.6 Ϯ 6.3 yr). Mitochondrial function [time constant of ADP (ADPtc)] was assessed during a 90-s unilateral isometric contraction using 31 P magnetic resonance spectroscopy, SI with an intravenous glucose tolerance test, body composition by dual-energy X-ray absorptiometry, and visceral adipose tissue (VAT) with computed tomography. ANOVA was used to compare AA and CA groups, and multiple linear regression modeling was used to identify independent predictors of SI. Between-race comparisons indicated that muscle oxidative capacity was lower among AAs vs. CAs (ADPtc: 25.6 Ϯ 9.8 vs. 21.4 Ϯ 9.9 s). Multiple linear regression models for the dependent variable SI contained 1) VAT and race and 2) VAT, race, and ADPtc. Significant independent effects for all predictor variables were observed in both the first (r 2 ϭ 0.345) and second (r 2 ϭ 0.410) models. The partial correlation for race was lower in the second model (Ϫ0.404 vs.
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The higher incidence of type 2 diabetes among African Americans (AAs) compared with Caucasian Americans (CAs) may be due, in part, to lower S I among AAs vs. CAs (12, 13, 29) . The physiological explanation for the observed lower S I in AAs compared with CAs is not known. Racial differences in muscle mitochondrial function may contribute to racial differences in S I . Although it has been demonstrated that AA women have lower muscle mitochondrial function than CA women (16), it is not known whether the difference in mitochondrial function explains the racial difference in S I . Understanding the physiological basis for racial differences in S I will become important as race-specific type 2 diabetes prevention strategies are developed and implemented.
Several clinical conditions often accompany decreased S I , such as obesity and deposition of visceral adipose tissue (VAT) (5) . Fat distribution, especially increased fat in the intraabdominal or visceral depot, is thought to play an important role in decreased S I . However, cross-sectional studies have shown that AA women have lower levels of VAT, both absolute and relative to total body fat mass, than do CAs (23, 39) . The paradoxical observation of AAs having both lower VAT and lower S I suggests that VAT may be serving as a surrogate for other body fat compartments with which it is highly correlated, and/or lower S I may be due to factors unrelated to and independent of VAT (10). Thus factors other than VAT must be invoked to explain lower S I among AAs. We examined the possibility that lower muscle mitochondrial function might contribute to lower S I among AAs.
Several studies (33, 35, 36) have shown greater whole body oxidative capacity to be associated with greater S I . Measures of in vivo mitochondrial function using 31 P magnetic resonance spectroscopy ( 31 P-MRS) have been correlated with whole body aerobic capacity (24) . The recovery rate of calculated free ADP, or the time constant of ADP (ADP tc ), has been used as a marker of mitochondrial function, one that is independent of pH (1, 2). Shorter recovery time constants denotes higher rates of ATP synthesis via oxidative phosphorylation.
The purpose of the present study was to examine the relationship between in vivo muscle mitochondrial function (as measured by ADP tc ) and whole body S I . Analysis of in vivo activity of skeletal muscle mitochondrial function will help to enhance our understanding of the role muscle mitochondrial function plays in S I . Even though associations between S I and mitochondrial function have been documented in at-risk individuals (e.g., offspring of type 2 diabetics) (30), to our knowledge, a statistically significant correlation between in vivo MRS measurements of mitochondrial function and S I has not been documented in a general population of healthy premenopausal women. A secondary aim was to determine whether differences in muscle mitochondrial function explain the difference in S I between AAs and CAs.
METHODS
Fifty-nine (37 CA, 22 AA) premenopausal women between the ages of 20 and 46 yr were studied in a "normal-weight" state, defined as a body mass index (BMI) of Ͻ25 kg/m 2 . Of the 59 women, 34 (58%) were originally recruited in an overweight (BMI 27-30 kg/m 2 ) and with a family history of overweight or obesity (BMI Ͼ27 kg/m 2 ) in at least one first-degree relative. Overweight women subsequently participated in a supervised weight loss program, during which they lost weight to achieve a "normal" BMI of Ͻ25 kg/m 2 . For the present study, these subjects were tested in an energy balance state after 4 wk of carefully supervised weight maintenance. The 34 postoverweight women included 14 AA and 20 CA women. The 34 postoverweight women were then group matched on the basis of age, race, and BMI, with 25 control subjects who reported never having been overweight or obese and not having had overweight or obese first-degree relatives. The control group included 9 AA and 16 CA women. For all subjects, race was based on self reports.
Subjects were not taking medications known to affect body composition, energy metabolism, fuel utilization, S I, heart rate, or thyroid status and did not smoke. The involvement of human subjects was approved by the Institutional Review Board of The University of Alabama, Birmingham, and all subjects provided written informed consent. Subjects were assessed during the follicular phase of the menstrual cycle. All volunteers were screened and briefed about the experimental protocol, and informed consent was obtained prior to any testing.
Study variables were assessed under weight-stable, diet-controlled conditions through the General Clinical Research Center (GCRC). Before each evaluation, all subjects were maintained in a weightstable state for 4 wk, during which all food was provided through the GCRC to maintain macronutrient intake within the range of 20 -22% of energy as fat, 16 -23% as protein, and 55-64% as carbohydrate. No alcohol intake was permitted. Dietary adherence and body weight were monitored twice a week. Subjects self reported themselves as sedentary (i.e., no regular exercise participation), and no attempt was made to alter their physical activity patterns.
Maximum aerobic capacity was assessed as maximal whole body aerobic capacity relative to total body mass (V O2 max) during a maximal modified Bruce-graded treadmill protocol and expressed relative to body weight and to fat-free mass (FFM). Consumption of oxygen and production of carbon dioxide were measured continuously via open-circuit spirometry and analyzed with the use of a metabolic cart (model 2900; SensorMedics, Yorba Linda, CA). Standard criteria for heart rate, respiratory quotient, and plateauing ensured achievement of V O2 max, as previously described (17) .
Collection of sera and tolbutamide-modified, frequently sampled, intravenous glucose tolerance test. At ϳ0700 after the subjects had fasted for 12 h, flexible intravenous catheters were placed in the antecubital spaces of both arms. Three blood samples were drawn over a 40-min period, and the sera were subsequently separated and pooled for analysis of lipids. Three additional blood samples were taken over a 20-min period for determination of basal glucose and insulin (the average of the values was used for basal fasting concentrations). At time 0, glucose (50% dextrose, 11.4 g/m 2 ) was administered intravenously. Blood samples (2.0 ml) were then collected at the following times (min) relative to glucose administration at 0 min: (3, 41) .
Assay of glucose and insulin. Glucose was measured in 10 l of serum by using an Ektachem DT II System (Johnson & Johnson Clinical Diagnostics, Rochester, NY). In our laboratory, this analysis has a mean intra-assay coefficent of variation (CV) of 0.61% and a mean interassay CV of 1.45%. Insulin was assayed in duplicate 200-l aliquots with Diagnostic Products (Los Angeles, CA) Coat-A-Count kits. According to the supplier, the cross reactivity of this assay with proinsulin is Ϸ40% at mid-curve; C-peptide is not detected. In our laboratory, this assay has a sensitivity of 11.4 pmol/l (1.9 IU/ml), a mean intra-assay CV of 5%, and a mean interassay CV of 6%. Commercial, quality control serum samples of low, medium, and high insulin concentration (Lyphochek; Bio-Rad, Anaheim, CA) were included in every assay to monitor variation over time, as described by Gower et al. (11) .
Analysis of skeletal muscle metabolism. 1 H-MRI and 31 P-MRS were conducted on a 4.1-T whole body imaging and spectroscopy system as previously described (24, 25, 26, 28) . Each subject was requested to fast and abstain from caffeinated beverages for Ն6 h and from exercise for Ն24 h prior to testing. The subjects performed unilateral isometric plantar flexion exercises using a lab-constructed exercise bench that attached to the patient table of the spectrometer. Isometric plantar flexion force was measured with this device, as previously described (24, 26, 27, 28) . After a warm up, in-magnet exercise periods consisted of a 90-s isometric plantar flexion at 100% of maximum voluntary contraction. A 7-cm 1 H/ 31 P surface coil was used to collect 2 s of time-resolved 31 P-MRS data during 60 s of rest, 90 s of exercise, and 7.5 min of recovery (24, 25, 28) . The coil was fastened to the underbelly of the calf muscle, centered about its maximum circumference.
31 P-MRS data were collected using the following parameters: TR ϭ 2,000 ms, 4 dummy pulses, one average, and a half-passage adiabatic excitation pulse.
Skeletal muscle mitochondrial function by ADPtc was determined using the model of Argov et al. (1) . Specifically, ADPtc was determined by fitting the recovery of each metabolite to a monoexponential curve, using Sigma Plot (Jandel Scientific; SPSS, Chicago, IL). A previous study (24) reported that recovery of ADP data obtained every 2 s is closely approximated by a mono-exponential curve. The ADPtc corresponded to the time required to lose ϳ63% of endexercise ADP concentration. The CV of ADPtc is 3.3% for exercise at this intensity (20) .
Body composition evaluation. Body composition was determined by dual-energy X-ray absorptiometry (DEXA) (DPX-L; Lunar Radiation, Madison, WI) with the use of software version 1.33 (Lunar Radiation). Cross-sectional areas of VAT and subcutaneous abdominal adipose tissue (SAAT) were determined by computed tomography (CT) with the use of a HiLight/HTD Advantage scanner (General Electric, Milwaukee, WI) set at 120 kVp (peak kilovoltage) and 40 mA. Subjects were examined in the supine position with their arms stretched above their heads, with a 5-mm scan taken for 2 s at the level of the umbilicus. With the use of procedures established by Kvist et al. (22) , the attenuation range for adipose tissue was Ϫ30 to Ϫ190 Hounsfield units. Cross-sectional areas of adipose tissue were determined by using a computerized fat tissue-highlighting technique. VAT and SAAT were measured by separating adipose tissue areas by encircling the muscle wall surrounding the abdominal cavity with a cursor. Tissue cross sections between Ϫ30 and Ϫ190 Hounsfield units in the respective areas were considered to be VAT and SAAT. Both intra-and interobserver test-retest reliability had an r value of 0.99 with a CV of Ͻ2% on the basis of reevaluation of 20 scans.
Statistical analysis.
Statistical analyses were performed with the use of SPSS software, version 11.0 (SPSS). Descriptive statistics are given as means Ϯ SD. For all analyses, values for S I were log transformed to eliminate skewness. Correlations between SI and morphological and mitochondrial variables were assessed using Pearson correlation coefficients. Multiple linear regression analysis was used to model the relationship between S I (dependent variable) and mitochondrial function and body composition (independent variables). The best multivariate model was selected on the basis of preliminary analysis using independent variables, with the largest simple correlations with S I and maximum R 2 . Two different models were tested. In the first model, race (AA vs. CA) and VAT were examined as predictors of S I. In the second model, race, VAT, and ADPtc were examined as predictors of SI. For all analyses, a P value Ͻ0.05 was deemed statistically significant.
RESULTS
The unadjusted descriptive statistics by race are displayed in Table 1 . AAs had lower S I and VAT and higher ADP tc (indicating lower muscle mitochondrial function) than did CA. The univariate relationships among the variables of interest are shown in Table 2 . S I was inversely correlated to ADP tc (r ϭ Ϫ0.360) and VAT (r ϭ Ϫ0.342). VAT was more strongly related to S I than was any other fat compartment measure, and thus the fat compartment was included in the multiple linear regression models. The association between ADP tc and VAT was not significant.
The mean 31 P data curves depicting depletion and recovery of ADP for each group are presented in Fig. 1 . This represents the ADP concentration data for the last exercise data point (at 90 s) through the first 260 s of recovery (i.e., until the ADP levels return to baseline values) and allows for visualization of the differences in oxidative phosphorylation between the two groups. An initial multiple linear regression model for the dependent variable S I using race (AA vs. CA) and VAT as independent variables is shown in Table 3 . Race and VAT were significant and independent predictors of S I . This first model explained ϳ34% of the variance of S I . V O 2 max adjusted for FFM was not a significant predictor of S I when included with race and VAT (Table 4) . However, with the inclusion of ADP tc into a model with race and VAT, all variables were significant and independent predictors of S I ( Table 5 ). The variance explained by this second model was 41%. The partial correlation for race decreased from model 1 to model 2 (Ϫ0.404 vs. Ϫ0.300) with the inclusion of ADP tc , suggesting that mitochondrial function explained part of the difference observed between AAs and CAs in S I .
DISCUSSION
This study was the first to test the hypothesis that mitochondrial function, measured in vivo, may contribute to the observed lower S I among healthy AAs compared with CAs. The results of this study indicated that, among premenopausal women, race, mitochondrial function, and VAT were independent predictors of S I . These results support the hypothesis that lower mitochondrial function might contribute to decreased S I in skeletal muscle (18, 19, 30) , and furthermore, racial differences in mitochondrial function may contribute to lower S I among AA vs. CA women. Values are means Ϯ SD. AA, African American; CA, Caucasian American; BMI, body mass index; VAT, visceral adipose tissue; ADPtc, time constant of ADP (lower values denote higher mitochondrial function);VO2 max, maximal whole body aerobic capacity relative to total body mass;VO2 max-FFM, maximal whole body aerobic capacity relative to fat-free mass; S1, insulin sensitivity. *AA vs. CA, P Ͻ 0.05. In agreement with other studies (6, 34), we found that VAT was an independent predictor of S I . Losses of VAT through diet-induced weight loss (8, 11) , and diet combined with 16 wk of moderate-intensity exercise, have been associated with increased S I (7) . The mechanisms thought to be responsible for the modulation of insulin action by VAT include increased portal release of free fatty acids (4, 40) and/or abnormal expression and secretion of fat-derived peptides, such as resistin (37), leptin, ACRP30, and tumor necrosis factor-␣ (15) .
ADP tc emerged as a significant independent predictor of S I in this study. This is consistent with the hypothesis that mitochondrial function is related to, and may be a contributing factor to, S I . In fact, ADP tc might even underestimate the contribution of mitochondrial function to S I . This could be because our measurements were confined to a single muscle group (gastrocnemius and soleus). The inclusion of measurements at other sites (e.g., latissimus dorsi, quadriceps) may strengthen the relationship we observed. Our observation that V O 2 max adjusted for FFM was not independently related to S I supported the hypothesis that the relationship between S I and mitochondrial function may be best assessed locally at the muscle level instead of globally with V O 2 max . Kelley et al. (19) suggested that lower S I may be due to some impairment at the level of glucose phosphorylation, transport, or both in the mitochondria. Petersen et al. (30) observed an ϳ30% reduction in mitochondrial function in insulin-resistant subjects compared with insulin-sensitive controls. Reductions in mitochondrial oxidative phosphorylation may lead to reduced fat oxidation, promoting accumulation of skeletal muscle lipid. Elevated muscle lipid may contribute to the development or progression of insulin resistance through activation of protein kinase C and the IB kinase/NF-B signaling pathways or local production of proinflammatory cytokines (32) .
The finding that race was a significant predictor of S I in both models was expected. Several studies (10, 11, 12, 13, 29) have found that AA had lower S I than CA; however, the physiological basis for lower S I among AA is still not clear. Lower VAT among AA suggests that differences in central vs. peripheral fat distribution do not explain lower S I among AA (12) . Furthermore, multiple linear regression analysis supported the notion that VAT does not account for the racial difference in S I . The addition of ADP tc into the multiple linear regression model decreased the partial correlation for race, suggesting that lower S I among AAs may be partially explained by lower muscle mitochondrial function. Lower whole body oxidative capacity in AAs compared with CAs has been observed in children (31, 38) and premenopausal women (16, 17) . Thus lower oxidative capacity, which has been associated with mitochondrial function (24) , may contribute to lower S I among AAs.
Taken together, our results suggest that muscle mitochondrial function plays a role in maintaining S I that is independent of fat distribution and race. These results are applicable only to normal-weight healthy premenopausal women, and we cannot speculate on the role that muscle mitochondrial function might play on S I in other groups. Furthermore, muscle mitochondrial function may explain, in part, the observed racial differences in S I . In this study, it was not possible to determine whether low S I was caused by impaired mitochondrial function or whether mitochondrial function was downregulated due to a decreased muscle energy demand (e.g., low physiological function and activity).
Although mitochondrial function has been previously studied in a resting basal state (30), we measured muscle under exercise conditions. This allowed us to measure the mitochondrial function capacity, which would be more representative of activated muscle. It would have been interesting to see the differences between the muscle's basal and perturbed conditions. Future studies should be done to measure both basal and perturbed mitochondrial function to get a more complete picture of the relationship between mitochondrial function and S I .
One of the limitations of our study was that we did not measure intramuscular lipids (IMCLs) in our subjects. Measures of IMCL would have considerably strengthened this study, because increased IMCL has been associated with type 2 diabetes (14) and decreased S I (9, 21) . Furthermore, measuring both resting and maximal mitochondrial function via MRS in conjunction with IMCL measures would allow a more complete insight into the interplay between S I and metabolism and should be considered in future studies. Future studies should also use a combination of MRI methods to measure blood flow and capillarization to thoroughly assess the role of mitochondrial function in determining S I . Finally, future studies should extend these experiments to determine whether acute or chronic exercise training improves mitochondrial function and S I . 
